Europe
The World Health Organization is launching a clinical trial in Norway and Spain to assess four of the most promising drugs in the fight against COVID-19, the disease caused by the novel coronavirus that has spread across the globe.
The two companies plan to focus their efforts on targeting several rare diseases.
One of the key takeaways from BIO-Europe Spring 2020 was that there is a keen need for greater collaboration and communications among the biotech community, government, non-governmental organizations and the public.
Although some clinical trials are being slowed or halted, others are reporting out data. Here’s a look.
A summary of daily biopharma industry news. Please check out stories that are trending on March 27, 2020.
Sanofi Pasteur and Translate Bio have partnered to develop a novel messenger RNA vaccine for COVID-19, the disease caused by the novel coronavirus.
Specifically, they will be looking at ways to improve processes by speeding up and reducing the cost of manufacturing.
Pharma and life sciences companies from across the globe provide updates on their pipelines and business.
A partial clinical hold placed at the end of last year remains in effect and the company has opted to terminate a trial in patients with multiple osteochondromas.
A summary of daily biopharma industry news. Please check out stories that are trending on March 26, 2020.
PRESS RELEASES